longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Berry Genomics

000710

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -14.25, within the reasonable range, cheaper than 42.48% of the time in the past 5 years, and the industry ranks 52/85, the industry Median 11.64.

-14.25xP/E
¥8.61Stock price
¥-0.60Earnings per share
-14.25xP/E
Stock price¥8.61Earnings per share¥-0.60

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-15.85x
Typical range
-25.60x–-9.44x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.64x
03876114152

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.64x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688180SHJunshi Biosciences
-75.69x92.53%¥33.37B
603392SHWantai Biological
-86.46x22.02%¥33.08B
300122SZZHIFEI-BIOL
-2.01x91.71%¥29.95B
688192SHDizal Pharmaceutical
-42.69x255.85%¥25.49B
300676SZBGI Genomics
-26.71x118.23%¥15.36B
688520SHSinocelltech
-17.06x171.21%¥15.30B
688765SHHEALTHGEN BIOTECH
-92.17x--¥12.73B
688062SHMabwell
-12.26x37.63%¥11.52B
688319SHOlymvax Biopharmaceuticals
-468.25x227.87%¥11.15B
300204SZStaidson BioPharm
-119.23x--¥10.72B
688105SHVazyme
-1,214.71x770.82%¥10.67B
688382SHInventisBio
-31.69x5.45%¥10.60B
688806SHTrinomab Pharmaceutical
-18.91x--¥9.65B
688759SHBeBetter Med
-53.17x12.50%¥9.44B
688443SHGenrix Bio
-14.63x32.19%¥8.23B
002030SZDAJY
-11.00x--¥7.51B
300294SZBOYA BIOLOGY
-116.52x281.82%¥7.16B
688177SHBIO-THERA
-15.17x2.47%¥6.96B
688276SHBCHT
-26.34x66.67%¥6.35B
688488SHAidea Pharma
-1,054.65x--¥6.11B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.